Evidence map›Paper›PMID 33321747›Full record

ArticleInternational journal of environmental research and public health2020

Assessment of a Screening Questionnaire to Identify Exposure to Lead in Pregnant Women.

Eléna Coiplet, Marine Freuchet, Claire Sunyach, Julien Mancini, Jeanne Perrin, Blandine Courbiere, Hélène Heckenroth, Christel Pissier, Naima Hamdaoui, Florence Bretelle

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eléna CoipletDepartment of Gynecology-Obstetric and Reproductive Medicine, Women-Parents-Children Centre (Pôle Femmes-Parents-Enfants/Hôpital La Conception), 147 Boulevard Baille, 13005 Marseille, France.
Marine FreuchetDepartment of Gynecology-Obstetric and Reproductive Medicine, Women-Parents-Children Centre (Pôle Femmes-Parents-Enfants/Hôpital La Conception), 147 Boulevard Baille, 13005 Marseille, France.
Claire SunyachDepartment of Gynecology-Obstetric and Reproductive Medicine, Women-Parents-Children Centre (Pôle Femmes-Parents-Enfants/Hôpital La Conception), 147 Boulevard Baille, 13005 Marseille, France.ORCID 0000-0003-1462-5610
Julien ManciniDepartment of Public Health, Aix-Marseille Univ, APHM, INSERM, IRD, SESSTIM, Hop Timone, BIOSTIC, (Biostatistiques et Technologies de L'information et de la Communication), 13005 Marseille, France.ORCID 0000-0001-9500-8598
Jeanne PerrinDepartment of Gynecology-Obstetric and Reproductive Medicine, Women-Parents-Children Centre (Pôle Femmes-Parents-Enfants/Hôpital La Conception), 147 Boulevard Baille, 13005 Marseille, France.
Blandine CourbiereDepartment of Gynecology-Obstetric and Reproductive Medicine, Women-Parents-Children Centre (Pôle Femmes-Parents-Enfants/Hôpital La Conception), 147 Boulevard Baille, 13005 Marseille, France.ORCID 0000-0002-1847-4509
Hélène HeckenrothDepartment of Gynecology-Obstetric and Reproductive Medicine, Women-Parents-Children Centre (Pôle Femmes-Parents-Enfants/Hôpital La Conception), 147 Boulevard Baille, 13005 Marseille, France.
Christel PissierPharmacokinetics and Toxicology Laboratory (Laboratoire de Pharmacocinétique et Toxicologie), AP-HM, 13005 Marseille, France.
Naima HamdaouiDepartment of Gynecology-Obstetric and Reproductive Medicine, Women-Parents-Children Centre (Pôle Femmes-Parents-Enfants/Hôpital La Conception), 147 Boulevard Baille, 13005 Marseille, France.
Florence BretelleDepartment of Gynecology-Obstetric and Reproductive Medicine, Women-Parents-Children Centre (Pôle Femmes-Parents-Enfants/Hôpital La Conception), 147 Boulevard Baille, 13005 Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lead readily crosses the placenta and displays adverse effects on birth outcomes and neurodevelopment. Systematic identification of the risk of exposure during pregnancy is essential but rarely performed, probably due to hospital staff's workload and their lack of awareness. We aimed to evaluate the relevance of a questionnaire to screen pregnant women for lead exposure. A cross-sectional, multicentre study was carried out on a population of 792 pregnant women from February 2018 to May 2020. A total of 596 women had a blood lead test: 68.5% had blood lead levels below 10 μg/L. The estimated prevalence above 25 µg/L was 4% (95% confidence interval (CI) [2.6-5.9]) and 1.3% had levels above 50 µg/L (95% CI [0.6-2.6]). Multivariate analysis showed that three risk factors significantly increased the probability of blood lead levels above 25 µg/L: the use of traditional cosmetics (adjusted odds ratio [aOR]: 3.90; 95% CI [1.65-9.21];

Indexed as

Environmental ExposureLeadPregnant PeopleSurveys and QuestionnairesAdultCross-Sectional StudiesFemaleHumansOdds RatioPregnancyRisk FactorsLeadenvironmentlead exposurepregnancyrisk factors

Identifiers

PMID33321747
PMCPMC7763227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.